Procter & Gamble Health Ltd.

Name: Procter & Gamble Health Ltd. Share Price Today, Stock Analysis
Brand: Procter & Gamble Health Ltd.

Stock Card

NSE: PGHL | BSE: 500126

₹5,452.00

₹-7.00 (-0.13%)

As on 23-Sep-2026IST

Market cap

₹9,032 Cr

Revenue (TTM)

₹1,433 Cr

P/E Ratio

25.3

P/B Ratio

14.7

Div. Yield

3.8 %

Value Research Rating

Quality Score

7/10

Growth Score

4/10

Valuation Score

5/10

Momentum Score

6/10

Know more

Explore 5 star rated stocks

Procter & Gamble Health Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 5,410.00 High: 5,515.50

52 Week Range

Low: 4,707.00 High: 6,975.00

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹357 Cr
ROE

62.2 %
ROCE

84.9 %
Industry P/E

34.25
EV/EBITDA

18.3
Debt to Equity

0
Book Value

₹370.9
EPS

₹200.7
Face value

10
Shares outstanding

16,599,382

10 Years Aggregate

CFO

₹1,653.24 Cr

EBITDA

₹2,560.43 Cr

Net Profit

₹1,857.08 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Procter & Gamble Health	-4.4	-6.5	-13.5	-12.8	3.9	0.3	22.3
BSE Healthcare	20.1	3.2	8.1	16.5	23.4	14.6	12.1

As on 23-Sep-2026

Company	2025	2024	2023	2022	2021	2020	2019
Procter & Gamble Health	9.3	5.5	25.2	-26.0	-23.5	54.6	38.3
BSE Small Cap	-6.6	29.0	47.5	-1.8	62.8	32.1	-6.8
BSE Healthcare	-3.3	43.1	37.0	-12.1	20.9	61.4	-3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Procter & Gamble Health	5,452.0	9,032.1	1,432.9	356.9	30.8	58.2	25.3	14.7
Astrazeneca Pharma	6,706.0	16,773.0	2,432.1	169.6	8.7	20.8	98.9	18.5
Bliss GVS Pharma	699.2	7,410.7	1,005.2	141.7	15.1	11.8	54.4	6.0
Caplin Point Lab	2,793.8	21,217.1	2,287.3	678.1	31.4	19.7	31.9	5.8
CORONA Remedies	2,163.4	13,237.2	1,479.1	198.6	18.6	30.3	66.5	16.4
Eris Lifesciences	1,269.9	17,617.7	3,229.7	666.9	26.6	18.8	27.4	4.4
Pfizer	4,025.5	18,377.3	2,569.8	735.2	34.4	19.2	25	4.2
Shilpa Medicare	1,037.7	20,283.8	1,682.5	273.5	21.0	11.1	68.2	7.6
Strides Pharma	1,223.3	11,294.4	5,004.4	635.3	14.5	19.8	18.4	3.4
Supriya Lifescience	1,000.9	8,054.7	872.6	198.4	29.7	17.4	40.6	6.6

Shareholding Pattern

View Details

News & Analysis

All News

Picking cold stocks and converting them to cool ones

2 min read•By Value Research

About Procter & Gamble Health

Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its... products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV. Read more

Incorporated

1967
Chairman

S Madhavan
Managing Director

Milind Thatte
Group

Merck - MNC
Headquarters

Mumbai, Maharashtra
Website

www.pghealthindia.com

Looking for more details about Procter & Gamble Health Ltd.’s IPO? Explore our IPO Details page.

FAQs for Procter & Gamble Health

What is the current share price of Procter & Gamble Health Ltd Today?

The share price of Procter & Gamble Health Ltd is ₹5,452.00 (NSE) and ₹5,441.25 (BSE) as of 23-Sep-2026 IST. Procter & Gamble Health Ltd has given a return of 3.89% in the last 3 years.

What is the current PB & PE ratio of Procter & Gamble Health Ltd?

The P/E ratio of Procter & Gamble Health Ltd is 25.31 times as on 23-Sep-2026, a 26 discount to its peers’ median range of 34.25 times.
The P/B ratio of Procter & Gamble Health Ltd is 14.67 times as on 23-Sep-2026, a 187 premium to its peers’ median range of 5.12 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2026	24.36	15.33
2024	41.71	15.83
2023	37.97	11.73
2022	36.10	11.41
2021	52.52	13.27

What is the 52 Week High and Low of Procter & Gamble Health Ltd?

The 52-week high and low of Procter & Gamble Health Ltd are Rs 6,975.00 and Rs 4,707.00 as of 23-Sep-2026.

What is the market cap of Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd has a market capitalisation of ₹ 9,032 Cr as on 23-Sep-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Procter & Gamble Health Ltd?

Before investing in Procter & Gamble Health Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.